top of page

CANNABINOID SCIENCE, BUILT FOR MEDICINE

Medical cannabis, held to pharma-grade standards.

IMCI formulations are built on NanoVATE Delivery™, our nano-emulsion platform, for higher bioavailability, faster onset and more consistent absorption than standard cannabis oil. We offer them to licensed partners in regulated medical cannabis markets.

Conceptual illustration of cannabinoid droplets in a nano-emulsion

THE DELIVERY ADVANTAGE

Higher exposure. Faster delivery.

Cobalt accents on pure white-5.png

Higher exposure

Than oil-based comparators, in IMCI’s preclinical and early human studies.

Cobalt blue design on white-4.png

Within minutes

THC detected in the blood with the sublingual format, in preclinical studies.

Cobalt accents on pure white-5.png

Peer-reviewed

Human data on the underlying technology.

WORK WITH IMCI

Who we work with.

Investors

Medical cannabis is moving from flower to pharma-grade. See the opportunity and why now.

​

​

Healthcare professionals

Physicians and pharmacists. See the evidence behind the platform, and how our formulations are specified and tested.

Researchers

Academic and clinical researchers working on cannabinoid compositions. We collaborate on formulation and pharmacokinetic studies.

Partners

Distributors, pharmacies and licensed operators. We offer three supply routes, matched to each market’s regulation.

NANOVATE DELIVERY™

Cannabinoids don’t mix with water. NanoVATE Delivery™ changes that.

Cannabinoids are fat-soluble, so standard cannabis oils are absorbed slowly and unevenly. NanoVATE Delivery™ forms nano-sized droplets on contact with water or body fluids, keeping cannabinoids dispersed and ready for absorption.

higher peak blood levels in a published human study of the underlying technology

Higher peak blood levels in the same study, compared with an approved oromucosal cannabinoid spray.

THC detected in the blood in IMCI's preclinical studies of the sublingual format

Illustration of an oil droplet dispersing into smaller droplets

Self-Emulsifying

Droplets form spontaneously, with no special preparation.

Conceptual illustration of liquid droplets and solid dosage formats

Liquid and Solid Format

L-NanoVATE for liquids, S-NanoVATE for tablets, capsules and edibles.

HOW WE SUPPLY

One platform. Three market-ready routes.

Each market regulates medical cannabis differently. We formulate NanoVATE Delivery™ products for the supply route each market requires.

iCann Fast CBD-rich Night Care tablet pack and blister

Final dosage form

Finished medical cannabis products, ready for dispensing, for supply under each market’s medical cannabis framework. 

Israel / United Kingdom / Australia

iCann Oral product jars for magistral preparations

Magistral

Formulations supplied to pharmacies that compound medical cannabis on prescription. 

Germany / Switzerland

NanoVATE premix and excipients containers

PreMix

A standardized cannabinoid ingredient for licensed manufacturers to use in their own products. 

United States

OUR BRANDS

Two brands, one platform.

iCann medical product range with tablet and capsule packaging

iCann

Our medical range, built on NanoVATE Delivery™ and supported by scientific research.

Ci adult-use product collection with chocolate, drink, pouch and gummy packaging

Ci

Our leisure line, built on the same platform. We work flexibly with licensed partners, including private label under the partner’s own brand.

SCIENCE AND RECOGNITION

Research with a path to market.

GET IN TOUCH

Let’s talk.

Physician, pharmacist, distributor or investor, tell us what you need and the right person on our team will follow up.

IMCI Pharmaceuticals is a pharmaceutical company developing cannabinoid formulations. Statements describe platform characteristics and are not medical claims for any specific product. Product availability, labeling and marketing are subject to each market’s regulations.

bottom of page